148 related articles for article (PubMed ID: 38400590)
1. Iron restriction in sickle cell disease: When less is more.
Castro OL; De Franceschi L; Ganz T; Kanter J; Kato GJ; Pasricha SR; Rivella S; Wood JC
Am J Hematol; 2024 Jul; 99(7):1349-1359. PubMed ID: 38400590
[TBL] [Abstract][Full Text] [Related]
2. The oral ferroportin inhibitor vamifeport improves hemodynamics in a mouse model of sickle cell disease.
Nyffenegger N; Zennadi R; Kalleda N; Flace A; Ingoglia G; Buzzi RM; Doucerain C; Buehler PW; Schaer DJ; Dürrenberger F; Manolova V
Blood; 2022 Aug; 140(7):769-781. PubMed ID: 35714304
[TBL] [Abstract][Full Text] [Related]
3. Hemoglobin S polymerization: primary determinant of the hemolytic and clinical severity of the sickling syndromes.
Brittenham GM; Schechter AN; Noguchi CT
Blood; 1985 Jan; 65(1):183-9. PubMed ID: 3965046
[TBL] [Abstract][Full Text] [Related]
4. Established and experimental treatments for sickle cell disease.
De Franceschi L; Corrocher R
Haematologica; 2004 Mar; 89(3):348-56. PubMed ID: 15020275
[TBL] [Abstract][Full Text] [Related]
5. Intracellular polymerization of sickle hemoglobin: disease severity and therapeutic goals.
Noguchi CT; Rodgers GP; Schechter AN
Prog Clin Biol Res; 1987; 240():381-91. PubMed ID: 3615501
[TBL] [Abstract][Full Text] [Related]
6. Improvement of sickle cell anemia by iron-limited erythropoiesis.
Castro O; Poillon WN; Finke H; Massac E
Am J Hematol; 1994 Oct; 47(2):74-81. PubMed ID: 7522396
[TBL] [Abstract][Full Text] [Related]
7. Impaired hemoglobin clearance by sinusoidal endothelium promotes vaso-occlusion and liver injury in sickle cell disease.
Kaminski TW; Katoch O; Li Z; Hanway CB; Dubey RK; Alagbe A; Brzoska T; Zhang H; Sundd P; Kato GJ; Novelli EM; Pradhan-Sundd T
Haematologica; 2024 May; 109(5):1535-1550. PubMed ID: 37941440
[TBL] [Abstract][Full Text] [Related]
8. Diagnosing sickle cell disease and iron deficiency anemia in human blood by Raman spectroscopy.
da Silva WR; Silveira L; Fernandes AB
Lasers Med Sci; 2020 Jul; 35(5):1065-1074. PubMed ID: 31637552
[TBL] [Abstract][Full Text] [Related]
9. Evolving treatment paradigms in sickle cell disease.
Jagadeeswaran R; Rivers A
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):440-446. PubMed ID: 29222291
[TBL] [Abstract][Full Text] [Related]
10. 2015 Clinical trials update in sickle cell anemia.
Archer N; Galacteros F; Brugnara C
Am J Hematol; 2015 Oct; 90(10):934-50. PubMed ID: 26178236
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide association study of erythrocyte density in sickle cell disease patients.
Ilboudo Y; Bartolucci P; Rivera A; Sedzro JC; Beaudoin M; Trudel M; Alper SL; Brugnara C; Galactéros F; Lettre G
Blood Cells Mol Dis; 2017 Jun; 65():60-65. PubMed ID: 28552477
[TBL] [Abstract][Full Text] [Related]
12. Interactions of an Anti-Sickling Drug with Hemoglobin in Red Blood Cells from a Patient with Sickle Cell Anemia.
Strader MB; Liang H; Meng F; Harper J; Ostrowski DA; Henry ER; Shet AS; Eaton WA; Thein SL; Alayash AI
Bioconjug Chem; 2019 Mar; 30(3):568-571. PubMed ID: 30794381
[TBL] [Abstract][Full Text] [Related]
13. Thrombosis and sickle cell disease.
De Franceschi L; Cappellini MD; Olivieri O
Semin Thromb Hemost; 2011 Apr; 37(3):226-36. PubMed ID: 21455857
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous polymerization and adhesion under hypoxia in sickle cell disease.
Papageorgiou DP; Abidi SZ; Chang HY; Li X; Kato GJ; Karniadakis GE; Suresh S; Dao M
Proc Natl Acad Sci U S A; 2018 Sep; 115(38):9473-9478. PubMed ID: 30190429
[TBL] [Abstract][Full Text] [Related]
15. Anion transport in normal erythrocytes, sickle red cells, and ghosts in relation to hemoglobins and magnesium.
Teti D; Venza I; Crupi M; Busà M; Loddo S; Romano L
Arch Biochem Biophys; 2002 Jul; 403(2):149-54. PubMed ID: 12139963
[TBL] [Abstract][Full Text] [Related]
16. Overview of pathophysiology and rationale for treatment of sickle cell anemia.
Rodgers GP
Semin Hematol; 1997 Jul; 34(3 Suppl 3):2-7. PubMed ID: 9317195
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiological insights in sickle cell disease.
Odièvre MH; Verger E; Silva-Pinto AC; Elion J
Indian J Med Res; 2011 Oct; 134(4):532-7. PubMed ID: 22089617
[TBL] [Abstract][Full Text] [Related]
18. Iron in sickle cell disease: a review why less is better.
Koduri PR
Am J Hematol; 2003 May; 73(1):59-63. PubMed ID: 12701123
[TBL] [Abstract][Full Text] [Related]
19. Mesoscopic Adaptive Resolution Scheme toward Understanding of Interactions between Sickle Cell Fibers.
Lu L; Li H; Bian X; Li X; Karniadakis GE
Biophys J; 2017 Jul; 113(1):48-59. PubMed ID: 28700924
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]